Ricerca avanzata

Attualmente, Howard A. Melnick ricopre la posizione di Chief Information Officer per Signet Jewelers Ltd. Fa anche parte del consiglio della United Way of Summit & Medina. Nella sua carriera passata ha occupato la posizione di Chief Information Officer di Ralph Lauren Corp.

Howard Horn è CFO, segretario e contabile principale di Vir Biotechnology, Inc. Horn ha precedentemente ricoperto la posizione di vicepresidente della pianificazione aziendale presso Biogen, Inc. e di analista presso UBS Securities LLC. Il signor Horn ha conseguito una laurea presso la Princeton University e un MBA presso la Wharton School of the University of Pennsylvania.

Attualmente, Dennis Howard occupa la posizione di Chief Information Officer & Executive VP per The Charles Schwab Corp. e Chief Information Officer & Executive VP presso Charles Schwab & Co. (una consociata della Charles Schwab Corp.). Il signor Howard è anche nel consiglio di amministrazione di SolarWinds Corp. e Chief Information Officer & Executive VP presso Charles Schwab & Co. In passato il sig. Howard è stato Chief Information Officer & Senior Vice President di Visa, Inc. e Presidente & Chief Executive Officer di Gillig LLC. Dennis Howard si è laureato alla Baylor University e si è laureato all'Università del Texas a San Antonio.

Fondatore di VCE Co. LLC, Howard D. Elias è attualmente presidente di TEGNA, Inc. e presidente di Dell Services, Digital & IT presso Dell Technologies, Inc. È anche nel consiglio di amministrazione di VCE Co. LLC e membro della Massachusetts Business Roundtable. In passato ha occupato la posizione di presidente e direttore operativo presso Global Enterprise Services, Inc., Senior VP-Business Management & Operations presso HP, Inc. Senior VP & GM-Business Critical Server Group presso Compaq Computer Corp. e Vicepresidente presso Digital Equipment Corp. (entrambe sono sussidiarie di HP, Inc.), COO-Global Enterprise Services presso EMC Corp., Vice Presidente-Marketing di AST Research, Inc. e Vice Presidente-Marketing di Tandy Corp.

Howard B. Hacker è Chief Compliance Officer di USPI Holding Co., Inc. e Chief Compliance Officer & Executive VP di Tenet Healthcare Corp.

Howard Schwimmer è co-amministratore delegato e direttore di Rexford Industrial Realty, Inc., amministratore delegato di Rexford Industrial Realty & Management, Inc. e membro del Consiglio direttivo dell'USC Lusk Center for Real Estate. Fa parte del Consiglio di amministrazione di Rexford Industrial Realty, Inc. Il signor Schwimmer è stato precedentemente impiegato come vicepresidente esecutivo e manager di DAUM Commercial Real Estate Services e presidente di USC Hillel. Ha ricevuto la sua laurea presso la University of Southern California.

Attualmente, Howard Liang ricopre la posizione di Chief Financial & Strategy Officer presso BeiGene Ltd. Il dottor Liang è anche nel consiglio di amministrazione di BeiGene (Guangzhou) Co., Ltd. e BeiGene Pharmaceuticals (Guangzhou) Co., Ltd. In passato il dottor Liang ha ricoperto la posizione di Senior Scientist presso Abbott Laboratories, Principal presso JMP Securities LLC, Vicepresidente presso A.G. Edwards & Sons, Inc., Managing Director presso SVB Leerink LLC e Senior Analyst presso Prudential Securities. Il dottor Liang ha conseguito un MBA e un dottorato presso l'Università di Chicago e una laurea presso l'Università di Pechino.

Il dottor Howard Mayer, MD, è vicepresidente esecutivo di ricerca e sviluppo presso Ipsen SA, direttore indipendente presso Entasis Therapeutics Holdings, Inc. e vicepresidente esecutivo, responsabile della ricerca e sviluppo presso Ipsen Pharmaceuticals, Inc. Fa parte del consiglio di amministrazione di Adagio Therapeutics, Inc., Entasis Therapeutics Holdings, Inc. e Melmark Charitable Foundation. Il Dr. Mayer è stato precedentemente impiegato come direttore indipendente da Genocea Biosciences, Inc., come Chief Medical Officer, Senior VP, Head-R&D da Shire Plc, come Chief Medical Officer da EMD Serono, Inc., come Head-Clinical Development & Medical Affairs da Pfizer Inc., come Director-Infectious Diseases Clinical Research da Bristol Myers Squibb Co. e come Head-Rare Disease Business Unit, R&D da Takeda Pharmaceuticals U.S.A., Inc. È stato anche membro del consiglio di amministrazione di Autism Speaks, Inc. Ha conseguito la laurea presso l'Università della Pennsylvania e il dottorato presso l'Albert Einstein College of Medicine, Inc.

Howard Boville worked as the Chief Technology Officer at Bank of America Corp.
and later served as the Senior Vice President-Cloud Platform at International Business Machines Corp.

Attualmente Kevin D. Howard occupa la posizione di Chief Accounting Officer, EVP & Controller presso Charter Communications, Inc. e CFO, CAO, Senior Vice President & Controller presso Charter Communications Holdings Capital Corp., Chief Accounting Officer, EVP & Controller presso CCO Holdings Capital Corp. e Chief Accounting Officer, EVP & Controller presso CCO Holdings LLC (che sono tutte filiali di Charter Communications, Inc.). Nella sua carriera passata il signor Howard è stato Chief Accounting Officer, SVP-Finance & Controller presso Charter Communications, Inc. e revisore di Arthur Andersen LLP. Kevin D. Howard si è laureato presso l'Università del Missouri.

Attualmente, Howard H. Yu è direttore finanziario e vicepresidente senior di Envista Holdings Corp. Nella sua carriera passata il signor Yu è stato direttore finanziario di Nobel Biocare AG, direttore finanziario di Ormco Corp. e vicepresidente della pianificazione e analisi finanziaria di Beckman Coulter, Inc. Howard H. Yu ha conseguito una laurea presso la University of California, Los Angeles e un MBA presso la University of Southern California.

La signora Gretchen Howard è un amministratore indipendente di Macondray Capital Acquisition Corp. I, un direttore operativo di Robinhood Markets, Inc. e un partner di CapitalG. Fa parte del consiglio di amministrazione di Macondray Capital Acquisition Corp. I, AllTrails, Inc e Williams College. La signora Howard è stata precedentemente impiegata come MD-Sales & Global Business Operations di Google, Inc. e Vice Presidente-Market Development & Field Sales di FMR LLC. Si è laureata al Williams College e ha conseguito un MBA alla Harvard Business School.

Fondatore di Sprout Social, Inc., Justyn Howard è attualmente presidente e amministratore delegato di questa azienda.

Howard Migdal is currently the Chief Executive Officer at Grubhub, Inc. starting in 2023.
Prior to this, he was the Chief Executive Officer at Skipthedishes Restaurant Services, Inc.

Howard Whyte worked as a Chief Information Security Officer at The Boeing Co. and Truist Financial Corp.

Attualmente, Howard I. Ungerleider occupa la posizione di presidente della Dow Silicones Corp. e presidente e direttore finanziario della Dow, Inc., presidente della Dorinco Reinsurance Co. e presidente e direttore finanziario della The Dow Chemical Co. Ltd. (entrambe sono filiali di Dow, Inc.). È anche presidente e direttore finanziario di The Dow Chemical Co. e vicepresidente dello sviluppo del Lake Huron Area Council e fa parte del consiglio di amministrazione di altre 5 società. Nella sua carriera passata, il signor Ungerleider è stato direttore finanziario della DuPont de Nemours, Inc. Howard I. Ungerleider ha conseguito una laurea presso l'Università del Texas a Austin e un MBA presso l'Università della California, Los Angeles.

Howard Bradley Schiller occupa la posizione di tesoriere e direttore presso Obagi Medical Products, Inc., direttore finanziario e tesoriere di Oceanside Pharmaceuticals, Inc., direttore finanziario e vicepresidente esecutivo di Bausch Health Americas, Inc., direttore finanziario e tesoriere di Prestwick Pharmaceuticals, Inc, direttore finanziario e tesoriere di Renaud Skin Care Laboratories, Inc., direttore finanziario e vicepresidente esecutivo di Aton Pharma, Inc., direttore finanziario e tesoriere di Private Formula Corp., direttore finanziario e tesoriere di Valeant Biomedicals, Inc., direttore finanziario e vicepresidente esecutivo di Princeton Pharma Holdings LLC, tesoriere e direttore di Solta Medical, Inc. e tesoriere e direttore di Sapphire Subsidiary Corp. È anche vicepresidente di OraPharma, Inc. e fa parte del consiglio di amministrazione di altre 7 società. Howard Bradley Schiller ha precedentemente occupato la posizione di direttore indipendente alla Bausch Health Cos. Direttore finanziario e vicepresidente esecutivo di Coria Laboratories Ltd. Chief Financial Officer & Executive Vice President di Bausch Health US LLC e Chief Financial Officer & Executive Vice President di Dow Pharmaceutical Sciences, Inc. (che sono tutte filiali di Bausch Health Cos., Inc.) e COO-Investment Banking Division presso The Goldman Sachs Group, Inc. Howard Bradley Schiller si è laureato alla University of Chicago Law School e si è laureato alla Wharton School of the University of Pennsylvania.

Howard Todd Stitzer è un uomo d'affari che è stato al timone di 5 diverse aziende e ricopre la posizione di presidente della Signet Jewelers Ltd. È anche nel consiglio della Massachusetts Mutual Life Insurance Co. e dello Springfield College. Nella sua carriera passata è stato amministratore delegato di Pepper, consigliere di Hamlin Capital Management LLC, amministratore delegato di Mondelez UK Ltd., amministratore delegato di Cadbury Ltd. e amministratore delegato di Mondelez UK Holdings & Services Ltd. Howard Todd Stitzer ha ricevuto un MBA dalla Harvard University e un dottorato dalla Columbia Law School.

Howard A. Willard è nel consiglio di Catalyst, Inc., U.S. Smokeless Tobacco Co. LLC e Extraction Oil & Gas, Inc. In precedenza ha ricoperto il ruolo di presidente, CEO, COO e vicepresidente esecutivo di Altria Group, Inc., vicepresidente esecutivo della responsabilità aziendale di Philip Morris USA, Inc. (una sussidiaria di Altria Group, Inc.), direttore di Bain & Co., Inc. e direttore di Salomon Brothers. Howard A. Willard ha conseguito un MBA presso l'Università di Chicago e una laurea presso la Colgate University.

Howard L. Lance è un uomo d'affari che è stato al timone di 11 diverse aziende. Lance ricopre la posizione di presidente di Change Healthcare, Inc., presidente di Change Healthcare Holdings, Inc. (una consociata di Change Healthcare, Inc.) e di Presidente di Summit Materials, Inc., Presidente di Summit Materials LLC (una consociata di Summit Materials, Inc.). Il signor Lance è anche nel consiglio di amministrazione di New Vista Acquisition Corp. In passato Lance è stato presidente, amministratore delegato e direttore di Maxar Technologies, Inc. Presidente, amministratore delegato e direttore di Maxar Technologies ULC e presidente, amministratore delegato e direttore di Macdonald Dettwiler & Associates Ltd., Inc. (entrambe controllate da Maxar Technologies, Inc.), Presidente, COO-Retail & Financial Group presso NCR Corp., EVP-Electronics & Telecommunications Business presso Emerson Electric Co., Presidente non esecutivo presso Harris Corp., Presidente, Amministratore delegato e Direttore presso MDA Systems Ltd. e Presidente, Amministratore delegato e Direttore presso Decision Insight Information Group (UK) Ltd. Lance si è laureato alla Bradley University e si è laureato alla Krannert School of Management.

Attualmente, Howard Watson occupa la posizione di Chief Technology & Information Officer presso BT Group Plc. In passato Watson ha ricoperto la posizione di amministratore delegato presso Signature Security Group Pty Ltd., Chief Transformation & Technology Officer presso Virgin Media, Inc., Managing Director-Networks presso Telewest Global, Inc. e Principal presso Marconi Corp. Plc.

Howard D. Schultz è presidente emerito di Starbucks Corp., presidente e amministratore delegato di Starbucks Coffee Singapore Pte Ltd., presidente e amministratore delegato di Starbucks Italy Srl e presidente, presidente e amministratore delegato di Starbucks Coffee Australia Pty Ltd. Fa parte del Consiglio di amministrazione di Pinkberry, Inc. e Starbucks Corp. Schultz è stato precedentemente impiegato come co-fondatore di Maveron LLC, co-fondatore di Schultz Family Foundation, presidente, presidente e amministratore delegato di IL Giornale Coffee Co, direttore di Retail Operations & Marketing di Starbucks Coffee Co, vicepresidente e direttore generale degli Stati Uniti di Hammarplast AB e presidente di The Basketball Club of Seattle LLC. Ha anche fatto parte del consiglio di amministrazione di Square, Inc., Groupon, Inc., DreamWorks Animation SKG, Inc. e Potbelly Sandwich Works LLC. Si è laureato alla Northern Michigan University.

Howard S. Marks, CFA MBA, è copresidente di Oaktree Capital Group LLC, copresidente di Oaktree Capital Management LP, presidente di Oaktree Capital LLC, copresidente di Oaktree Funds e fondatore di TCK Investments Co. Fa parte del consiglio di amministrazione di Brookfield Asset Management, Inc., University of Pennsylvania, Kerzner International Holdings Ltd., The Royal Drawing School e The Metropolitan Museum of Art. Marks è stato precedentemente impiegato come co-presidente di Oaktree Capital Management (UK) LLP, come fiduciario emerito della University of Pennsylvania, come presidente di Oaktree Capital Management LLC, come presidente di TCW Asset Management Co. LLC, Chief Investment Officer di The TCW Group, Inc., Vice President & Senior Portfolio Manager di Citicorp Investment Management, Inc., Trustee di The Mount Sinai Hospital e Trustee di The University of Pennsylvania. Si è laureato presso la Wharton School dell'Università della Pennsylvania e ha conseguito un MBA presso la Booth School of Business dell'Università di Chicago.

Howard Cyr is currently the Chief Compliance Officer & Vice President at Teleflex, Inc. Prior to this, he worked as the Senior Corporate Counsel at Pfizer Inc. from 2004 to 2010 and as the Associate General Counsel at Teva Pharmaceuticals USA, Inc. from 2010 to 2018.
Mr. Cyr received his undergraduate degree from Notre Dame University and his graduate degree from the University of Pittsburgh Law School.

Howard E.
Davis is currently the Chief Administrative & Information Officer, EVP at Transocean Ltd.
Prior to this, he was the Chief Administrative Officer & CIO, Vice President at National-Oilwell, Inc. from 2005 to 2015, and the SVP, Chief Administrative & Information Officer at NOV, Inc. from 1981 to 2015.
He received his undergraduate degree from the University of Kentucky in 1980.

Howard John Davies è un uomo d'affari britannico che è stato a capo di 7 diverse aziende e ricopre la posizione di presidente di NatWest Group Plc e di presidente di The Royal Bank of Scotland Plc. Davies è anche nel consiglio della Tate Gallery Foundation, Inc., Paternoster Plc e Natwest Holdings Ltd. e professore a Sciences Po. In precedenza è stato presidente della Airports Commission, presidente di Phoenix Group Plc, direttore di McKinsey & Co., Inc., direttore del Foreign & Commonwealth Office, presidente della Financial Services Authority, presidente di NatWest Markets Plc, presidente non esecutivo di PGH (Cayman), vice governatore della Bank of England e direttore generale della Confederation of British Industry.

Howard Fu is currently the Chief Financial Officer & Treasurer at Procore Technologies, Inc. He previously worked as the Vice President-FP&A at DocuSign, Inc. from 2015 to 2021.
He also held a position as Principal at Salesforce, Inc. Mr. Fu completed his graduate degree at Stanford University and holds an MBA from Yale University.
He obtained his undergraduate degree from the University of California, Berkeley.

Attualmente Howard A. Friedman occupa la posizione di direttore operativo e vicepresidente esecutivo di Post Holdings, Inc. In passato il signor Friedman è stato presidente e amministratore delegato di Post Consumer Brands LLC.

Richard J.
Melnick is currently a Shareholder at Greenberg Traurig LLP.
He obtained his undergraduate degree from Tufts University in 1973, and his graduate degrees from New York University in 1977 and Georgetown University in 1976.

Sean Alan Melnick is the founder of Peregrine Holdings Ltd.
(founded in 1996) and holds the title of Non-Executive Chairman.
He is currently the Chairman at Stenham Ltd.
(since 2008), Deputy Chairman at Peregrine SA Holdings Pty Ltd.
(since 2013), Director at Novogate Medical Ltd.
(since 2015), Director at Germane Financial Consulting (Pty) Ltd., Director at Apex HI UK Ltd., Director at Peregrine Advisory Services Ltd., Director at Capital Step Holdings Ltd., Director at Lincoln City Holdings Ltd.
(since 2018), Non-Executive Director at A2X Markets, and Trustee at Citadel Staff Share Trust.
He previously served as the Chief Executive Officer & Director at Zarclear Holdings Ltd.
(2017-2018), Non-Executive Chairman at Industrials REIT Ltd., Non-Executive Director at Consolidated Infrastructure Group Ltd.
(2019-2021), and Non-Executive Director at Aquis Exchange Plc.
He also worked as a Senior Portfolio Manager at Liberty Asset Management Ltd.
(Ireland).
Mr. Melnick completed his undergraduate degree at the University of the Witwatersrand in 1991.

Ms. Ivy Melnick is Portfolio Accountant at Hesperian Capital Management Ltd.

Bobby Melnick served as an Independent Director at Hampshire Group Ltd.
from 2013 to 2015.
He also worked as a General Partner at Terrier Partners LP.
Mr. Melnick received his undergraduate degree from Washington University in St. Louis in 1983 and his MBA from New York University in 1987.

Jeff Melnick is currently a Trustee at Community Associations Institute and the President at Boston Pizza Restaurants LP.
He previously worked as a Regional Director-Operations at Brinker International, Inc. from 2002 to 2006, and as an Area Director-Operations at Brinker Nevada, Inc. from 1995 to 2002.
He also worked as a Director at California Restaurant Association and as a Senior Vice President-Operations at Red Robin Gourmet Burgers, Inc. Mr. Melnick holds an undergraduate degree and an MBA from the University of Phoenix.

Jordan Melnick is currently working as Vice President at TJC LP since 2022.
He completed his undergraduate degree from The GW School of Business in 2013.

David Melnick held positions as Director-HIV Clinical Research at Kaiser Permanente of Mid Atlantic States, Vice President at AstraZeneca LP from 2008 to 2012, Vice President-Clinical Development at Allergan Ltd.
(Ireland), and Chief Medical Officer at Spero Therapeutics, Inc.

Steven Melnick currently works as a Director at Nicklaus Children's Hospital.

Richard Melnick currently works at The Minerva Institute for Research & Scholarship, as Trustee.

Matt Melnick has worked as a Vice President of Operations at Slang Worldwide, Inc. since 2016.

Stan Melnick is currently the Chief Financial Officer at Mobile Macs Pty Ltd.
He previously worked as the Financial Director at The House of Busby (Pty) Ltd.
from 2000 to 2004 and as the Managing Director at Genesis Capital Partners (Pty) Ltd.
from 2005 to 2020.
He obtained an undergraduate degree from the University of the Witwatersrand.

Andrew Joseph Melnick is the founder of SkyView Investment Advisors LLC, which was founded in 2009.
He is currently the Managing Partner & Chief Investment Strategist at SkyView Investment Advisors LLC.
He also holds current positions as Director at SystemForward America, Inc., Independent Director at Lakeview Acquisition Corp., Trustee at Monmouth Medical Center, Inc., Commissioner at Monmouth County Improvement Authority (New Jersey), and Member-Governors Board at The American Jewish Committee.
Mr. Melnick has held former positions as Non-Executive Chairman at Acuity Knowledge Partners (UK) Ltd., Director-Global Securities & Senior Vice President at Merrill Lynch & Co., Inc., Independent Director at CreditRiskMonitor.com, Inc., Managing Director at PSD Capital LLC, Research Director & Partner at L.
F.
Rothschild, Unterberg, Towbin, Inc., Director at The New York Society of Security Analysts, Inc., Chief Investment Strategist at BPV Capital Management LLC, Partner at Goldman Sachs & Co. LLC, Senior Analyst at Drexel Burnham Lambert, Inc., President at Woolcott Corp.
Development Pty Ltd., and Partner at Skyview Investments Ltd.Mr. Melnick's education history includes undergraduate and MBA degrees from Rutgers State University of New Jersey.

Mike Melnick was the founder of Cell Signaling Technology, Inc. (founded in 1999) where he held the title of Vice President-Business Development in 2006.
He is currently working as Vice President-CMC at BioAtla, Inc. and as an Investor at Baruch Future Ventures LLC.
In his former positions, he served as Acting Chief Executive Officer at Biolight Harvesting, Inc., Chairman at Inventure Renewables, Inc., Director at Wildcat Discovery Technologies, Inc., Chief Scientific Officer at Microvi Biotech, Inc., Venture Partner at Presidio Partners (2011-2014), and Chief Commercial Officer at Assay Designs, Inc. (2007).
He also worked as a Principal at New England Biolabs, Inc. in 1999.
Dr. Melnick obtained a doctorate degree from Harvard University and completed his undergraduate and graduate studies at Stanford University.

Perri Melnick currently works at Association of Corporate Counsel, as Member, The State Bar of California, as Member, American Health Lawyers Association, as Member, The Los Angeles County Bar Association, as Member, and Women Lawyers Association of Los Angeles, as Member.
Ms. Melnick also formerly worked at IPC Healthcare, Inc., as Vice President-Legal Affairs.
Ms. Melnick received her undergraduate degree from the University of Massachusetts and graduate degree from Loyola Law School.

Larry Melnick has a current job as a Life Director at Camp Twin Lakes, Inc.

Ari Melnick is currently the Director at The Leukemia & Lymphoma Society, Inc. He obtained a doctorate degree from the University of Buenos Aires School of Medicine.

Robert A.
Melnick is currently working as a Business Manager at Prestige Imports, Inc. He previously worked as a Director at Genesis Solar Corp.
from 2004 to 2011.
He also held positions as a Finance Director at Chesrown Automotive Group, Inc. and as a Principal at AutoNation, Inc. Melnick holds a graduate degree from Carnegie Mellon University and an undergraduate degree from Drake University.

Jonathan Melnick worked as a Research Director at Lux Research, Inc. from 2017 to 2020.
Before that, he held positions at Lux Research, Inc. from 2011 to 2017.
Dr. Melnick has a graduate and doctorate degree from The Trustees of Columbia University in The City of New York, and an undergraduate degree from Syracuse University.

Sue Melnick has a current job as the Chief Operating & Compliance Officer at Bay Equity LLC.

Mr. Steven L.
Melnick, CFA, is a Research Analyst at Brown Advisory LLC.
He joined the firm in June 2015 as a result of the partnership between Brown Advisory and Highmount Capital.
Mr. Melnick joined Highmount in January 2015 as an associate director, assisting with the firm’s third-party manager due diligence efforts.
Prior to Highmount, he spent two years at Dyson Capital Advisors working directly with the Chief Investment Officer in assembling a diversified investment platform.
He began his career at Cambridge Associates where he spent two years focusing on private investments research.
He received his undergraduate degree from George Washington University.

Lloyd Melnick is the founder of Merscom LLC, which was founded in 1999.
He held the title of Chief Customer Officer from 2010 to 2011.
Currently, Mr. Melnick is an Independent Director at Real Luck Group Ltd.
since 2020 and a General Manager at VGW Holdings Ltd.
since 2019.
Previously, he worked as a Director-StarsPlay at The Stars Group, Inc. from 2015 to 2019 and as a Senior Director at Zynga, Inc. from 2013 to 2015.
Mr. Melnick holds an MBA from Duke University, an undergraduate degree from The Johns Hopkins University, and a graduate degree from the University of Limerick.

Paul C.
Melnick is currently the Director-Special Assets at CIBM Bank since 2009.
Prior to his current position, he served as the Chief Credit Officer at CIB Marine Bancshares, Inc. from 1999 to 2021.

Keith D.
Melnick is currently the Chief Executive Officer & Director at Insurance Zebra, Inc. Prior to his current position, he worked as a Team Leader at American Airlines, Inc. from 1996 to 1999.
He also served as a Management Consultant at The Boston Consulting Group, Inc. and as the Executive Vice President-Business Development at KAYAK Software Corp.
from 2004 to 2010.
Mr. Melnick holds an MBA from the University of Southern California and an undergraduate degree from the University of Illinois.

Rick Melnick has worked as a Director at the Biopesticide Industry Alliance since 2013.

Leandro Melnick is currently the Chairman and Chief Executive Officer & Director at Melnick Desenvolvimento Imobiliário SA. He is also a Director at Even Construtora e Incorporadora SA since 2017.
Mr. Melnick has an undergraduate degree from Universidade Federal do Rio Grande do Sul and a graduate degree from Getulio Vargas Foundation.